Researcher

My Expertise

Quantification of smoking in Australian and international settings 

Quantification of benefits of smoking cessation

Viruses and cancer (KSHV/HHV-8, HIV, HPV, Helicobacter pylori)

COVID-19 and smoking

COVID-19 and e-cigarettes

e-cigarettes and cancer

Keywords

Fields of Research (FoR)

Epidemiology, Public health, Epidemiological methods, Oncology and carcinogenesis, Public Health and Health Services

SEO tags

Biography

A/Prof Freddy Sitas is the Chief Operations Officer at International Centre for Future Health Systems, Operationally responsible for centre set-up, developing and implementing operational plans, development of terms of reference, Multi Institutional Agreements, research strategy and capacity development, and reporting.  He is also Adjunct Associate Professor at the School of Population Health, UNSW Sydney.

He has made a significant...view more

A/Prof Freddy Sitas is the Chief Operations Officer at International Centre for Future Health Systems, Operationally responsible for centre set-up, developing and implementing operational plans, development of terms of reference, Multi Institutional Agreements, research strategy and capacity development, and reporting.  He is also Adjunct Associate Professor at the School of Population Health, UNSW Sydney.

He has made a significant contribution in the design and implementation of policy relevant population and clinical infrastructure studies on chronic disease prevention. He has worked extensively with cancer, mortality statistics and other large health related datasets. He has led several collaborations and consortia and has published extensively quantifying the effects of environmental and lifestyle factors such as smoking, BMI, alcohol and infection on cancer and premature mortality, and received the Oettlè Memorial Medal for his work in 2014. His current interests include how the primary care sector can become more involved in prevention of chronic disease, quantifying the benefits of smoking cessation after hospitalisation, and quantifying the effects of smoking on infectious respiratory disease, and quantifying / identifying (cancer) risks in relation to e-cigarette use. Invited assessor of the Cancer Surveillance Branch at International Agency for Research on Cancer, Nuffield Cancer Epidemiology Unit, University of Oxford. Operationally responsible for centre set-up, operational plans, development of terms of reference, multi-institutional research agreements, research strategy and capacity development, and reporting.  

Membership of external committees

Clinical Oncology Society of Australia Working Groups: 1) Smoking cessation after cancer 2) E-cigarettes and cancer. Review of current evidence. 

Editor-in-Chief: Cancer Epidemiology, Elsevier Press I.F. 3.0. 

Board member of Infection and Cancer Research Unit, University of the Witwatersrand.

 


My Grants

  • Gale M, Bolton P ... Taylor N... Sitas F.  Stop Smoking Start Living - TRGS award, $0.5m 2022-2024
  • Harris Roxas ... Sitas F Implementation and evaluation of "Shisha No Thanks" intervention Cancer Institute grant 2022 - 2024 $100,000 
  • Sarah Lewington, Margo Barr, Freddy Sitas) Smoking and infectious respiratory diseases: a preliminary analysis of large epidemiological studies (Pump Priming Grant Nuffield Department of Population Health) $10,000
  • Maigen Zhou, Pang Li, Hang Li, Adair T, Sitas F, Lopez AD, Study on SmartVA for diagnosis COVID-19 deaths and the contribution of smoking to COVID-19 deaths in Wuhan, China. Bloomberg Foundation, University of Melbourne. $125,720
  • Harris MF, Sitas F. Priority Research Support Program Grant, NSW Ministry of Health 2022-2026 1.2m, $300K per annum.
  • De Leeuw E, Barr M, Sitas F, Fatima K. Inequality Partnership research proposal. ACOSS $67,000, 2019-2020
  • Bradshaw D (PI), Mathew C, Lewis C, Babb C, Singh E, Newton R, Waterboer T, Sitas F (CoPI). Evolving risk factors for cancers in African populations (ERICA-SA).  Lifestyle, infection, genetic susceptibility and cancer in South Africa: development of research capacity and an evidence base for cancer control £800,000, 2017-2023
  • Liauw T, Jonnagaddala J ...Sitas F. Unifying and quality assuring disparate health silos with a common data model.  NHMRC Partnership Grant 1.2m, 2021-2024 

My Qualifications

BSc (U. WITS),

MSc (Med) (U. WITS),

MSc (Epidemiology (London School of Hygiene and Tropical Medicine),

D.Phil (Epidemiology) (U. Oxford)


My Awards

2013: George Oettlè Award for contribution to cancer research

2015: Carnegie Corporation of New York-Witwatersrand University Diaspora Fellow

2024: Australasian Epidemiology Association Lifetime Achievement Award, Fellow of the Australasian Epidemiology Association (FAEA)


My Research Activities

Smoking questions on death notification forms - Implementation in Australian Jurisdictions

Analysis of 3.4 m adult and 1 m 18-34 year old mortality records with smoking information from South Africa (MRC South Africa). 

E-cigarettes and cancer; Clinical Oncological Society of Australia evidence review  

EVOLVING RISK FACTORS FOR CANCERS IN AFRICAN POPULATIONS: Lifestyle, infection, genetic susceptibility and cancer in South Africa: development of research capacity and an evidence base for cancer control (MRC South Africa, German Cancer Research Centre, Kings College London, MRC AIDS Virus Research Institute, Uganda, National Health Laboratory Service, South Africa)

COVID-19, Lower Respiratory Tract infections and Smoking.  

Vaping, smoking and hospitalisations among young populations 

Quantifying survival benefits of smoking cessation after a cancer diagnosis

 

 


My Research Supervision


Areas of supervision

Quantifying benefits of smoking cessation after cancer / hospitalisation

COVID and smoking

infectious respiratory disease and smoking

smoking, vaping and hospitalisation in young adults

e-cigarettes and cancer

 

 

 

 

View less

Location

Level 5 Health Translation Hub

Contact

+61-2-90658007